HomeCompareESSA vs PFE

ESSA vs PFE: Dividend Comparison 2026

ESSA yields 2.91% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ESSA wins by $330.1K in total portfolio value
10 years
ESSA
ESSA
● Live price
2.91%
Share price
$20.61
Annual div
$0.60
5Y div CAGR
55.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$379.6K
Annual income
$210,681.63
Full ESSA calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — ESSA vs PFE

📍 ESSA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodESSAPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ESSA + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ESSA pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ESSA
Annual income on $10K today (after 15% tax)
$247.45/yr
After 10yr DRIP, annual income (after tax)
$179,079.39/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, ESSA beats the other by $156,759.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ESSA + PFE for your $10,000?

ESSA: 50%PFE: 50%
100% PFE50/50100% ESSA
Portfolio after 10yr
$214.6K
Annual income
$118,470.18/yr
Blended yield
55.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

ESSA
Analyst Ratings
2
Hold
Consensus: Hold
Altman Z
-0.8
Piotroski
5/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ESSA buys
0
PFE buys
0
No recent congressional trades found for ESSA or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricESSAPFE
Forward yield2.91%6.13%
Annual dividend / share$0.60$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR55.8%13.2%
Portfolio after 10y$379.6K$49.6K
Annual income after 10y$210,681.63$26,258.71
Total dividends collected$341.3K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldHold

Year-by-year: ESSA vs PFE ($10,000, DRIP)

YearESSA PortfolioESSA Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,154$453.57$9,153$693.39+$2.0KESSA
2$12,671$736.61$8,593$849.25+$4.1KESSA
3$14,776$1,218.47$8,336$1,066.78+$6.4KESSA
4$17,880$2,068.99$8,437$1,384.80+$9.4KESSA
5$22,777$3,645.32$9,013$1,875.40+$13.8KESSA
6$31,133$6,761.58$10,306$2,680.72+$20.8KESSA
7$46,769$13,457.28$12,820$4,101.38+$33.9KESSA
8$79,479$29,436.46$17,673$6,826.70+$61.8KESSA
9$157,882$72,839.13$27,543$12,591.86+$130.3KESSA
10$379,615$210,681.63$49,560$26,258.71+$330.1KESSA

ESSA vs PFE: Complete Analysis 2026

ESSAStock

ESSA Bancorp, Inc. operates as a bank holding company for ESSA Bank & Trust that provides a range of financial services to individuals, families, and businesses in Pennsylvania. The company accepts savings accounts, interest bearing demand accounts, checking accounts, money market accounts, club accounts, certificates of deposit and IRAs, and other qualified plan accounts, as well as commercial checking accounts. Its loan portfolio includes first mortgage loans for the purchase, construction, or refinancing of one- to four-family residential real estate property; commercial real estate loans; home equity loans and lines of credit; and commercial and other consumer loans, as well as loans secured by deposits and personal unsecured loans. In addition, the company offers insurance benefits consulting services, such as health insurance, life insurance, short term and long term disability, dental, vision, 401(K) retirement planning, and individual health products, as well as asset management and trust, and investment services. As of September 30, 2021, it operated 21 community offices, including seven offices in Monroe County, three offices in Lehigh County, five offices in Northampton County, one office in Lackawanna County, one office in Luzerne County, one office in Chester County, two offices in Delaware County, and one office in Montgomery County, Pennsylvania. The company was founded in 1916 and is headquartered in Stroudsburg, Pennsylvania.

Full ESSA Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this ESSA vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ESSA vs SCHDESSA vs JEPIESSA vs OESSA vs KOESSA vs MAINESSA vs JNJESSA vs MRKESSA vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.